Head: Kaidashev Ihor P.. A multicenter, randomized, double-blind, placebo-controlled phase III study administered in parallel groups to evaluate the safety, tolerability, and efficacy of bilastine eye drops in adults, 0.6% solution. Ukrainian medical stomatological Academy. № 0120U104539

Updated: 2026-10-22